Provided by Tiger Fintech (Singapore) Pte. Ltd.

Hutchison China Meditech

14.38
-0.5100-3.43%
Volume:97.76K
Turnover:1.41M
Market Cap:2.46B
PE:71.90
High:14.50
Open:14.50
Low:14.29
Close:14.89
Loading ...

Bristol Myers says Phase 3 ODYSSEY-HCM Camzyos trial did not meet endpoints

TIPRANKS
·
Yesterday

Bristol Myers Squibb Provides Update on Phase 3 ODYSSEY-HCM Trial

Business Wire
·
Yesterday

Paychex Completes Acquisition of Paycor

Business Wire
·
14 Apr

Engineering and Construction Companies Lay the Groundwork for Growth and Innovation with Oracle Fusion Cloud Applications

PR Newswire
·
10 Apr

Biotech Stock Roundup: PCRX Up on Patent News, EWTX Down on Study Data & More

Zacks
·
10 Apr

Tampa Bay Buccaneers Expand Dayforce Partnership

GlobeNewswire
·
09 Apr

3 Internet Delivery Services Stocks in Focus Amid Industry Challenges

Zacks
·
08 Apr

Is Workday Inc. (WDAY) the Best Enterprise Software Stock to Buy Now?

Insider Monkey
·
06 Apr

Edgewise Therapeutics (EWTX): Among Unstoppable Stocks That Could Double Your Money

Insider Monkey
·
06 Apr

Analysts Expect Breakeven For Asure Software, Inc. (NASDAQ:ASUR) Before Long

Simply Wall St.
·
04 Apr

Safe Harbor Financial and Würk Partner to Expand Access to Cannabis Financial Services and Workforce Solutions

GlobeNewswire
·
03 Apr

Cytokinetics: A Promising Investment with Aficamten’s Competitive Edge in HCM Treatment

TIPRANKS
·
03 Apr

Tenaya Therapeutics Announces Late Breaker Presentation of New Data from MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 at American College of Cardiology Annual Meeting

GlobeNewswire
·
31 Mar

Why Cytokinetics, Incorporated (CYTK) Is the Best Mid Cap Biotech Stock to Buy

Insider Monkey
·
31 Mar

Is Tenaya Therapeutics, Inc. (TNYA) the Cheapest Stock Insiders Are Buying In March?

Insider Monkey
·
28 Mar

Evisort AI-Powered Contract Intelligence Now Available Through Workday

PR Newswire
·
27 Mar

Rimini Street Launches Rimini Manage™ for Workday

Business Wire
·
27 Mar

Infosys Powers LKQ Europe's HR Transformation with a Unified Digital Platform

PR Newswire
·
27 Mar

Edgewise Therapeutics to Host Webcast Event to Discuss Top-Line Results from Phase 2 CIRRUS-HCM 28-Day Trial of EDG-7500 in Hypertrophic Cardiomyopathy (HCM) on Wednesday, April 2 at 8:30 am Eastern Time

PR Newswire
·
27 Mar

HCM II Acquisition to Merge With Next-Generation Nuclear Reactor Company; Shares Climb

MT Newswires Live
·
26 Mar